Medicare cost containment strategy targets several oncology drugs.
Twombly
Renee
R
D000970:Antineoplastic Agents / Q000191:economics*; D003363:Cost Control; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D006278:Medicare / Q000191:economics*; D011306:Prescription Fees; D012051:Reimbursement Mechanisms; D014481:United States
D000970:Antineoplastic Agents